Apple on Track for Lowest Close Since May 2023 — Data Talk
Apple Inc. (AAPL) is currently at $166.84, down $1.16 or 0.69%
--Would be lowest close since May 4, 2023, when it closed at $165.79
--Currently down four consecutive days; down 5.5% over this period
--Longest losing streak since March 7, 2024, when it fell for seven straight trading days
--Worst four day stretch since the four days ending March 7, 2024, when it fell 5.93%
--Down 2.7% month-to-date
--Down 13.34% year-to-date
--Down 15.78% from its all-time closing high of $198.11 on Dec. 14, 2023
--Up 0.12% from 52 weeks ago (April 20, 2023), when it closed at $166.65
--Down 15.78% from its 52-week closing high of $198.11 on Dec. 14, 2023
--Up 1.88% from its 52-week closing low of $163.76 on April 26, 2023
--Traded as low as $166.63; lowest intraday level since Oct. 26, 2023, when it hit $165.67
--Down 0.82% at today's intraday low
--Fifth most active stock in the S&P 500 today
--Fourth most active stock in the Nasdaq 100 today
--Subtracted 7.62 points from the DJIA so far today
All data as of 1:38:15 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 18, 2024 13:55 ET (17:55 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters